This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Perez F, El Chakhtoura NG, Papp-Wallace KM, Wilson BM, Bonomo RA. Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy? Expert Opinion on Pharmacotherapy. 2016;17: 761–781.PerezFEl ChakhtouraNGPapp-WallaceKMWilsonBMBonomoRATreatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?Expert Opinion on Pharmacotherapy20161776178110.1517/14656566.2016.1145658Search in Google Scholar
Perez F, Bonomo RA. Evidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteria. Lancet Infectious Diseases. 2018;18: 358–360.PerezFBonomoRAEvidence to improve the treatment of infections caused by carbapenem-resistant Gram-negative bacteriaLancet Infectious Diseases20181835836010.1016/S1473-3099(18)30112-9Search in Google Scholar
Abdallah M, Balshi A. First literature review of carbapenem-resistant Providencia. New Microbes New Infections. 2018;25: 16–23.AbdallahMBalshiAFirst literature review of carbapenem-resistant ProvidenciaNew Microbes New Infections201825162310.1016/j.nmni.2018.05.009603124129983987Search in Google Scholar
Sharma D, Sharma P, Soni P. First case report of Providencia Rettgeri neonatal sepsis. BMC Research Notes. 2017;10: 536.SharmaDSharmaPSoniPFirst case report of Providencia Rettgeri neonatal sepsisBMC Research Notes20171053610.1186/s13104-017-2866-4566305729084590Search in Google Scholar
Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, et al. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: Report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party. Journal of Antimicrobial Chemotherapy. 2018;3: 73–78.HawkeyPMWarrenRELivermoreDMMcNultyCAMEnochDAOtterJATreatment of infections caused by multidrug-resistant Gram-negative bacteria: Report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working PartyJournal of Antimicrobial Chemotherapy20183737810.1093/jac/dky02729514274Search in Google Scholar
Shin S, Jeong SH, Lee H, Hong JS, Park M-J, Song W. Emergence of multidrug-resistant Providencia rettgeri isolates co-producing NDM-1 carbapenemase and PER-1 extended-spectrum beta-lactamase causing a first outbreak in Korea. Annals of Clinical Microbiology and Antimicrobials. 2018;1: 17–20.ShinSJeongSHLeeHHongJSParkM-JSongWEmergence of multidrug-resistant Providencia rettgeri isolates co-producing NDM-1 carbapenemase and PER-1 extended-spectrum beta-lactamase causing a first outbreak in KoreaAnnals of Clinical Microbiology and Antimicrobials201811720Search in Google Scholar
Douka E, Perivolioti E, Kraniotaki E, Fountoulis K, Economidou F, Tsakris A, et al. Emergence of a pandrug-resistant VIM-1-producing Providencia stuartii clonal strain causing an outbreak in a Greek intensive care unit. International Journal of Antimicrobial Agents. 2015;45: 533–536.DoukaEPerivoliotiEKraniotakiEFountoulisKEconomidouFTsakrisAEmergence of a pandrug-resistant VIM-1-producing Providencia stuartii clonal strain causing an outbreak in a Greek intensive care unitInternational Journal of Antimicrobial Agents20154553353610.1016/j.ijantimicag.2014.12.03025749199Search in Google Scholar
Zavascki AP, Carvalhaes CG, da Silva GL, Soares SFT, de Alcåntara LR, Elias LS, et al. Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit. Infection Control Hospital Epidemioogyl. 2012;33: 627–630.ZavasckiAPCarvalhaesCGda SilvaGLSoaresSFTde AlcåntaraLREliasLSOutbreak of carbapenem-resistant Providencia stuartii in an intensive care unitInfection Control Hospital Epidemioogyl20123362763010.1086/66573022561721Search in Google Scholar
Makris D, Petinaki E, Tsolaki V, Manoulakas E, Mantzarlis K, Apostolopoulou O, et al. Colistin versus colistin combined with ampicillin-sulbactam for multiresistant acinetobacter baumannii ventilator-associated pneumonia treatment: an open-label prospective study. Indian Journal Critical Care Medicine. 2018;22: 67–77.MakrisDPetinakiETsolakiVManoulakasEMantzarlisKApostolopoulouOColistin versus colistin combined with ampicillin-sulbactam for multiresistant acinetobacter baumannii ventilator-associated pneumonia treatment: an open-label prospective studyIndian Journal Critical Care Medicine201822677710.4103/ijccm.IJCCM_302_17584246029531445Search in Google Scholar
Zalts R, Neuberger A, Hussein K, Raz-Pasteur A, Geffen Y, Mashiach T, et al. Treatment of carbapenem-resistant acinetobacter baumannii ventilator-associated pneumonia: retrospective comparison between intravenous colistin and intravenous ampicillin-sulbactam. American Journalof Therapeutics. 2016;23: 78–85.ZaltsRNeubergerAHusseinKRaz-PasteurAGeffenYMashiachTTreatment of carbapenem-resistant acinetobacter baumannii ventilator-associated pneumonia: retrospective comparison between intravenous colistin and intravenous ampicillin-sulbactamAmerican Journalof Therapeutics201623788510.1097/MJT.0b013e3182a32df324263165Search in Google Scholar
Ranzani OT, Prina E, Torres A. Nosocomial pneumonia in the intensive care unit: how should treatment failure be predicted? Revista Brasileira de terapia intensiva. 2014;26: 208–211.RanzaniOTPrinaETorresANosocomial pneumonia in the intensive care unit: how should treatment failure be predicted?Revista Brasileira de terapia intensiva20142620821110.5935/0103-507X.20140032Search in Google Scholar
Fisher K, Trupka T, Micek ST, Juang P, Kollef MH. A prospective one-year microbiologic survey of combined pneumonia and respiratory failure. Surgical Infections. 2017;18: 827–833.FisherKTrupkaTMicekSTJuangPKollefMHA prospective one-year microbiologic survey of combined pneumonia and respiratory failureSurgical Infections20171882783310.1089/sur.2017.11128880805Search in Google Scholar
Sah R, Khadka S, Shrestha GS, Acharya S, Aryal D, Shrestha P, et al. Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal. Antimicrobial Resistance & Infection Control. 2019;8: 155.SahRKhadkaSShresthaGSAcharyaSAryalDShresthaPDetection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in NepalAntimicrobial Resistance & Infection Control2019815510.1186/s13756-019-0608-1679482431636898Search in Google Scholar
Hara GL, Gould I, Endimiani A, Pardo PR, Daikos G, Hsueh PR, et al. Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: Recommendations from an International Working Group. Journal of Chemotherapy. 2013;25: 129–140.HaraGLGouldIEndimianiAPardoPRDaikosGHsuehPRDetection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: Recommendations from an International Working GroupJournal of Chemotherapy20132512914010.1179/1973947812Y.000000006223783137Search in Google Scholar
Tshisevhe VS, Lekalakala MR, Tshuma N, van Rensburg SJ, Mbelle N. Outbreak of carbapenem-resistant Providencia rettgeri in a tertiary hospital. South African Medical Journal. 2017;107: 36–38.TshisevheVSLekalakalaMRTshumaNvan RensburgSJMbelleNOutbreak of carbapenem-resistant Providencia rettgeri in a tertiary hospitalSouth African Medical Journal20171073638Search in Google Scholar
